Vertical transmission of human immunodeficiency virus

QJM: An International Journal of Medicine

Volumn 90, Issue 1, 1997, Pages 5-12

  Morrison, J ^a   Alp, N J ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WOLFSON COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0031028357     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.1.5     Document Type: Review

References (73)

1. Gayle HD, Gnaore E, Adjorlolo G, Ekpini E, Coulibaly R, Porter A, Braun MM, Zabban ML, Andou J, Timite A, et al. HIV-1 and HIV-2 infection in children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 1992; 5(5):513-17.
2. Chin J. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet 1990; 336:221-4.
3. World Health Organisation. 13 million HIV positive women by 2000. Geneva, WHO, September 1993 (press release WHO/69).
4. Courgnaud V, Laure F, Bignozzi C, Goudneau A, Barin F, Brechot C. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retro viruses 1991; 7:337.
5. Mano H, Chermann JC. Fetal immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses 1991; 7:83.
6. Brossard Y, Aubin JT, Mandelbrot L, Bignozzi C, Brand D, Chaput A, Roume J, et al. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995; 9(4):359-66.
7. Kesson AM, Fear WR, Williams I, Chang J, King AJ, Cunningham AL. HIV infection of placental macrophages: their potential role in vertical transmission. J Leukoc Biol 1994; 56(3):241-6.
8. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ, and The International Registry of HIV-exposed Twins. High risk of HIV infection for first born twins. Lancet 1991; 338:1471.
9. Tan X, Pearce-Pratt R, Phillips DM. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J Virol 1991; 67(11):6447-52.
10. Henin Y, Mandelbrot L, Henrion R, Pradineaud R, Pontagnier L. HIV in the cervicovaginal secretions of pregnant and non-pregnant women. J Aquir Immun Defic Syndr 1993; 6:72-5.
11. The European Collaborative Study. Caesarian section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343:1464-7.
12. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, Garcia P, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996; 334:1617-23.
13. Krevine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet 1992; 339:1187-9.
14. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, Valleron AJ. Timing of mother-to-child transmission depends on maternal status. The HIV Infection in Newborns French Collaborative Study Group. AIDS 1993; 7 Suppl 2:49-52.
15. Fang G, Burger H, Grimson R, Tropper P, Nachman S, Mayers D, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995; 92:12100-4.
16. Ziegler JB, Cooper DA, Johnson RO, Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; i:896-8.
17. Stiehm ER, Vink P. Transmission of human immunodeficiency virus infection by breast feeding. J Paediatr 1991; 118:410.
18. Thiry L, Sprecher-Goldberger S, Jonckherr T, et al. Iosolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985; ii:891-2.
19. Cutting WA. Breast-feeding and HIV - a balance of risks. J Trop Pediatr 1994; 40(1):6-11.
20. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, Nagelkerke NJ, Maitha G, Holmes KK, Piot P, et al. Mother-to-child transmission of human immunodeficiency virus type 1: Report from the Nairobi Study. J Infect Dis 1994; 70(5):1134-40.
21. Colebunders R, Kapita B, Nekwei W, et al. Breastfeeding and transmission of HIV. Lancet 1988; ii:1487.
22. Nduati RW, John GC, Kreiss J. Postnatal transmission of HIV-1 through pooled breast milk. Lancet 1994; 344:1432.
23. Cutting WAM. Breastfeeding and HIV in African countries. Lancet 1994; 343:362.
24. Hu DJ, Heyward WL, Byers RH Jr, Nkowane BM, Oxtoby MJ, Holck SE, Heymann DL. HIV infection and breast-feeding: policy implications through a decision analysis model. AIDS 1992; 6(12):1505-13.
25. Del-Fante P, Jenniskens F, Lush L, Morona D, Moeller B, Lanata CF, Hayes R. HIV, breast-feeding and under-5 mortality: modelling the impact of policy decisions for or against breast-feeding. J Trop Med Hyg 1993; 96(4):203-11.
26. Nagelkerke NJ, Moses S, Embree JE, Jenniskens F, Plummer FA. The duration of breastfeeding by HIV-1-infected mothers in developing countries: balancing benefits and risks. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8(2):176-81.
27. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991; 337:253-60.
28. Ryder RW, Manzila T, Baende E, et al. Evidence from Zaire that breast-feeding is not a major route for perinatal HIV-1 transmission but does decrease morbidity. AIDS 1991; 5:709-14.
29. Halsley NA, Boulos R, Holt E, et al. Transmission of HIV-1 infections from mothers to infants in Haiti: impact on child mortality and malnutrition. JAMA 1990; 264:2088-92.
30. Kanki PJ, Travers KU, Mboup S, Hsieh C-C, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Alvila M, Sankale J-L, Ndoye I, Essex ME. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943-6.
31. Coulter JBS. HIV infection in African children. Ann Trop Paediatr 1993; 13(2):205-15.
32. Gayle HD, Gnore E, Adjorlolo G, Eklpini E, Coulobaly R, Porter A, Braun MM, Zabban ML, Andou J, Timite A, et al. HIV-1 and HIV-2 infection in children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 1992; 5:513-17.
33. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, Lauritzen E. HIV-2 infection in Bissau, West Africa, 1987-1989: incidence, prevalence, and routes of transmission. J Acquir Immune Defic Syndr 1993; 6(8):941-8.
34. Buseyne F, Blanche S, Schmitt D, Griscelli C, Riviere Y. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol 1993; 150:3569-81.
35. Morgan G, Wilkins HA, Pepin J, Jobe O, Brewster D, Whittle H. AIDS following mother-to-child transmission of HIV-2. AIDS 1990; 4(9):879-82.
36. Ryder RW, Hassig SE. The epidemiology of perinatal transmission of HIV. AIDS 1988; 2 (Suppl 1):83-9.
37. Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ. Factors predicitive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994; 271(24):1925-30.
38. + levels. J Acquir Immune Defic Syndr 1994; 7(7):718-26.
39. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of human immunodeficiency virus type 1 to infancts of seropositive women in Zaire. N Engl J Med 1989; 320:1638-42.
40. Feyno EM, Morfeldt-Manson L, Chiodi F, Lind B, von Gegerfelt A, Albert J, Olausson E, Asjo B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988; 62:4414-9.
41. Roques P, Marce D, Courpotin C, Mathieu FP, Herve F, Boussin FD, Narwa R, Meyohas MC, Dollfus C, Dormont D. Correlation between HIV provirus burden and in utero transmission. AIDS 1993; 7 (Suppl 2):39-43.
42. Klicks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994; 272(6):467-74.
43. Lamers SL, Sleasman JW, Xiong She J, Barrie KA, Pomeroy SM, Barrett DJ, Goodenow MM. Persistence of multiple maternal genotypes of Human Immunodeficiency Virus type 1 in infants infected by vertical transmission. J Clin Invest 1994; 93:380-90.
44. Tovo PA, de Martino M, Gabiano C, Tibaldi C, Vierucci C, Veglia F. AIDS appearance in children is associated with the velocity of disease progression in their mothers. J Infec Dis 1994; 170(4):1000-2.
45. Bulterys M, Chao A, Dushimimana A, Habimana P, Nawrocki P, Kurawige JB, Musanganire F, Saah A. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS 1993;7(12): 1639-45.
46. Ross AC. Vitamin A status: relationship to immunity and the antibody response. J Soc Exp Biol Med 1992; 200:303-20.
47. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 43:1593-7.
48. Tang A, Graham NMH, Kirby J, et al. Dietary micronutrient intake and risk of progression to AIDS in HIV-1 infected homosexual men. Am J Epidemiol 1993; 138:937-51.
49. Semba RD, Muhilal Ward BJ, et al. Abnormal T-cell subset proportions in vitamin A-deficient children. Lancet 1993; 341:5-8.
50. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346:530-36.
51. Yap KL, Ada GL, McKenzie IFC. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978; 273:238-40.
52. Zinkernagel RM, Doherty PC. Restriction of in vitro cell-mediated cytotoxicity in lymphocytic choriomeningitic within a syngenetic or semisyngenetic system. Nature 1974; 248: 701-2.
53. Bjorkman PJ, Saper MA, Samraoui B, Beennet WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen HLA-A2. Nature 1987a.; 329:506-12.
54. Bjorkman PJ, Saper MA, Samraoui B, Beennet WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987b; 329:512-16.
55. Elliot T, Driscoll P, Smith M, McMichael AJ. Peptide epitope selection by class I MHC molecules. Curr Biol 1994; 3:854-66.
56. Carmichael A, Jin X, Sissons J, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1) specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993; 177:249.
57. Buseyne F, Blanche S, Schmitt D, Griscelli C, Riviere Y. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol 1993; 150:3569-81.
58. Cheynier R, Langlae-Demoyen P, Marescot M-R, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, Plata F. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992; 22:2211-17.
59. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K, McMichael A. HIV-specific cytotoxic T cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341:861-62.
60. Aldhous MC, Wateret KC, Mok JYQ, Bird AG, Froebel KC. Cytotoxic T lymphocyte activity in an HIV-exposed but uninfected infant. Clin Exp Immunol 1994; 97:61-7.
61. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodefieciency virus type 1 (HIV-1)-specific cytotoxic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170:1296-9.
62. Borkowsky W, Krasinski K, Paul D, et al. Human immunodeficiency virus type 1 antigenaemia in children. J Pediatr 1989; 114:940-5.
63. De Rossi A, Ades AE, Mammano F, et al. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS 1991; 5:15-20.
64. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen ISY. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995; 332:833-8.
65. Villiari P, Spino C, Chalmers TC, Lau J, Sacks HS. Caesarian section to reduce perinatal transmission of human immunodeficiency virus. A metanalysis. Online J Curr Clin Trials 1993; Jul 8:no 2.
66. The European Collaborative Study. Caesarian section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343:1464-7.
67. Smith JR, Kitchen VS. Reducing the risk of infection for obstetricians. Br J Obstet Gynaecol 1991; 98:124-6.
68. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind placebo controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343:871-81.
69. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331(18):1173-80.
70. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373 (6510):123-6.
71. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373 (6510):117-22.
72. Kumar RM, Hughes PF, Khurranna A. Zidovudine use in pregnancy: a report on 104 cases and the occurence of birth defects. J Acquir Immune Defic Syndr 1994; 7(10):1034-9.
73. Siegrist C-A, Yerly S, Kaiser L, Wyler C-A, Perrin L. Mother to child transmission of zidovudine-resistant HIV-1. Lancet 1994; 344:1771-2.